Skip to main content

Table 8 EU Guidelines, quality indicators (with accepted and desired levels)

From: Introduction of organised mammography screening in tyrol: results of a one-year pilot phase

  Tyrol 50-69 EU-accepted EU-desired
Attendance proportion 54.2 >70 >75
Recall rate1) 3.1 (327/10521) <7%/
<5%
<5%/
<3%
Interval cancer rate/Background incidence rate (BIR) 0-11 months 9% (two interval cancers in age 50-69) 30% <30%
Breast cancer detection rate 2.3 * BIR 3*BIR >3*BIR
Stage II+/Total cancers screen-detected 38.0% (19/50) NA <30%
Invasive cancers ≤ 10 mm/Total invasive cancers 34.0% (16/47) NA >= 25%
Proportion of invasive cancers that are < 15 mm in size 51.1% (24/47) 50% >50%
Invasive cancer/Total cancers screen-detected 94% (47/50) 90% 80%-90%
Node-negative cancer/Total invasive cancers screen-detected 66.0% (31/47) NA >70%
Benign to malignant open surgical biopsy ratio 0:1 (0:4) <=1:2 <=1:4
Benign to malignant core biopsy ratio 1:0.9 (60:64)   
  1. 1) Recall is defined as call for further assessment or invitation to intermediate screening within six months